RxDoctor Payments Data

Samuel Seltzer, MD

Ophthalmology · Florence, SCNPI 1053379107

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.4% of the total across 55 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Alcon accounts for 75.4% of it on its own, with 10 other manufacturers making up the rest.

$2,753in general payments, 2019–2025

Across 55 payments — averaging $50.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$2K
  • Rxsight Inc$206
  • Johnson & Johnson Surgical Vision, Inc.$124
  • Mallinckrodt Hospital Products Inc.$109
  • Sight Sciences, Inc.$88
  • Novartis$38
  • plus $111 from 5 others
$32,019in research payments, 2019–2025

Across 48 payments — averaging $667.05 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Alcon Research LLC$25K
  • AbbVie$7K

What the payments were for

  • Speaking & faculty fees$391%
  • Food & beverage$2,59894%
  • Education$1164%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,753 in reported general payments places this provider in the 60th percentile of 293 ophthalmology providers in South Carolina.

See all ophthalmology providers in South Carolina

Medicare billing

Part B allowed, 2024
$538,354
Medicare patients
645
Services billed
3,382

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate688$38,680
Diclofenac Sodium673$10,568
ProlensaBromfenac Sodium25$9,275
Latanoprost126$1,487
Ketorolac Tromethamine36$1,142
Timolol Maleate61$1,037
Brimonidine Tartrate40$713
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat19$473
Ofloxacin18$299
Dorzolamide Hcl18$285

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Florence

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →